Legislative Assembly for the ACT: 2019 Week 11 Hansard (Thursday, 26 September 2019) . . Page.. 4011 ..
The procedures for updating the asset register are documented in the Canberra Health Services Standard Inclusion suite of documents that are used for maintenance and capital project delivery.
(4) ACT Health Directorate and Canberra Heath Services undertake annual stocktakes as per the Director General Financial Instruction and Chief Executive Officer Financial Instruction respectively.
(5) ACT Health Directorate asset management coordinator manages the identification and disposal of assets, guided by the Director General Financial Instruction (6.1 Asset Management). Assets identified for disposal are removed from the asset register and disposed of in accordance with the instructions. Canberra Health Services Chief Executive Officer Financial Instructions requires an annual stocktake of assets.
Canberra Health Services requires delegate approval prior to commencing actions to dispose of registered asset items. Following approval, the item is removed from the asset register and the physical asset is disposed of appropriately.
(6) ACT Health Directorate has updated Director General Financial Instruction (6.1 Asset Management) to reflect the recommendations of the Axiom audit report including implementation of an asset management action plan.
Following the Axiom report a Strategic Asset Management Plan was developed. Following this Facilities Management are undertaking a facility asset audit project (described in the Q1 response above), developing building asset management plans, and upgrading and enhancing the enterprise asset management system.
Health—PBS medications(Question No 2576)
Mrs Dunne asked the Minister for Health, upon notice, on 2 August 2019:
(1) In relation to the Government’s response to recommendation 18, about the Public Hospital Pharmaceutical Reform Agreement (PHPRA), of the report No 6 Annual and Financial Reports 2017-18 of the Standing Committee on Health, Ageing and Community Services, (a) to what extent and (b) in what ways, does the “ACT’s alternative arrangement [ensure] that patients’ access to PBS [Pharmaceutical Benefits Scheme] medications is not limited”.
(2) How did the ACT draw that conclusion.
(3) What is the (a) nature and (b) detail, of “the ACT’s alternative arrangement”.
(4) Has the ACT communicated to the Commonwealth its conclusion that the PHPRA limits patients’ access to PBS medications; if no, why; if yes, what was the Commonwealth’s response.
(5) To what extent and in what ways, does the PHPRA limit patients’ access to PBS medications in those jurisdictions that have signed the Agreement.
Ms Stephen-Smith: The answer to the member’s question is as follows: